Compare Enveric Biosciences Inc (ENVB) vs Vivmark Residential Common Shares of Beneficial Interest (VMRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.80M), while Vivmark Residential Common Shares of Beneficial Interest trades at $60.64 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is far larger — about 6825× Enveric Biosciences Inc's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.68% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and Vivmark Residential Common Shares of Beneficial Interest for 0 Days on average.
| ENVB | VMRK | |
|---|---|---|
Market Cap | $6.80M | $46.41B |
Volume | 64,867 | 6,584,008 |
Sector | Health | Real Estate |
52-Week High | $10.80 | $70.15 |
52-Week Low | $1.27 | $57.98 |
Typical Hold Time | 14 Days | 0 Days |
Enterprise Value | -$1.49M | $55.52B |
Dividend Yield | — | 4.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.45, down 3.01% on the day, with a bearish technical signal driven by moving averages. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten quarterly EPS expectations. Recent positive developments include a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in investor conferences.
The outlook is mixed; analyst consensus is 75% buy with strong earnings beats, but high negative ROE/ROA and operational cash burn pose significant risks. Investment opportunity hinges on successful drug development, while key risks include funding needs and clinical trial outcomes.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Vivmark Residential Common Shares of Beneficial Interest
Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →
